LACK OF IMPACT OF BASELINE RESISTANCE-ASSOCIATED VARIANTS (RAVS) ON TREATMENT OUTCOME IN THE AVIATOR STUDY WITH ABT-450/R, ABT-333 AND ABT-267, +/- RIBAVIRIN

被引：6
|
作者：
Krishnan, P. [1 ]
Tripathi, R. [1 ]
Irvin, M. [1 ]
Beyer, J. [1 ]
Reisch, T. [1 ]
Schnell, G. [1 ]
Xie, W. [1 ]
Zhou, X. [1 ]
Larsen, L. [1 ]
Kofron, J. [1 ]
Cohen, D. [1 ]
Podsadecki, T. [1 ]
Pilot-Matias, T. [1 ]
Collins, C. [1 ]
机构：
[1] AbbVie Inc, N Chicago, IL USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)61390-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1230
引用
收藏
页码：S498 / S498
页数：1
相关论文
共 33 条
  • [1] ABT-450/ritonavir and ABT-267 in combination with ABT-333 for the treatment of hepatitis C virus
    Minaei, Ashley Arezou
    Kowdley, Kris V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (06) : 929 - 937
  • [2] Safety and Efficacy of Interferon-free Regimens of ABT-450/r, ABT-267, ABT-333 ± Ribavirin in Patients with Chronic HCV GTI Infection: Results from the Aviator Study
    Kowdley, Kris
    Lawitz, Eric
    Poordad, Fred
    Cohen, Daniel
    Nelson, David
    Zeuzem, Stefan
    Everson, Gregory
    Kwo, Paul
    Foster, Graham
    Sulkowlski, Mark
    Xie, Wangang
    Larsen, Lois
    Khatri, Amit
    Podsadecki, Thomas
    Bernstein, Barry
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S108 - S108
  • [3] Safety of Ribavirin-containing Regimens of ABT-450/r, ABT-333, and ABT-267 for the Treatment of HCV Genotype 1 Infection and Efficacy in Subjects with Ribavirin Dose Reductions
    Cohen, Daniel E.
    Xie, Wangang
    Larsen, Lois
    Marincic, Christal
    Knauss-Townsend, Mary
    Khatri, Amit
    Podsadecki, Thomas
    Bernstein, Barry
    HEPATOLOGY, 2013, 58 : 754A - 755A
  • [4] Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects.
    Badri, P.
    Cohen, D.
    Ding, B.
    Podsadecki, T.
    Bernstein, B.
    Awni, W.
    Dutta, S.
    Menon, R.
    TRANSPLANTATION, 2014, 98 : 736 - 736
  • [5] Pharmacokinetics, Safety and Tolerability of Cyclosporine or Tacrolimus Following Coadministration of ABT-450/r, ABT-267 and ABT-333 in Healthy Subjects.
    Badri, P.
    Cohen, D.
    Ding, B.
    Podsadecki, T.
    Bernstein, B.
    Awni, W.
    Dutta, S.
    Menon, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 736 - 736
  • [6] SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333+/- RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
    Kowdley, K. V.
    Lawitz, E.
    Poordad, F.
    Cohen, D. E.
    Nelson, D.
    Zeuzem, S.
    Everson, G. T.
    Kwo, P.
    Foster, G. R.
    Sulkowski, M.
    Xie, W.
    Larsen, L.
    Khatri, A.
    Podsadecki, T.
    Bernstein, B.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S2 - S2
  • [7] Pharmacokinetics and Safety of Co-administered ABT-450 plus Ritonavir (ABT-450/r), ABT-267 and ABT-333 as a Single Dose in Subjects with Normal Hepatic Function and in Subjects with Mild, Moderate and Severe Hepatic Impairment
    Khatri, Amit
    Gaultier, Isabelle A.
    Menon, Rajeev
    Marbury, Thomas C.
    Lawitz, Eric
    Podsadecki, Thomas J.
    Mullally, Victoria
    Awni, Walid M.
    Bernstein, Barry
    Dutta, Sandeep
    HEPATOLOGY, 2012, 56 : 555A - 556A
  • [8] THE EFFECT OF IL28B POLYMORPHISMS ON VIROLOGIC RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN (SOC) ADDED TO ABT-450/RITONAVIR (ABT-450/R), ABT-333, OR ABT-072
    Gaultier, I.
    Cohen, D. E.
    Bhathena, A.
    Idler, K.
    Larsen, L. M.
    Podsadecki, T.
    Bernstein, B.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S523 - S523
  • [9] SAPPHIRE II: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN TREATMENT-EXPERIENCED ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1
    不详
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S1 - S1
  • [10] SERUM miR-122 MAY SERVE AS A BIOMARKER FOR RESPONSE TO DIRECT ACTING ANTIVIRALS: EFFECT OF ABT-450/r WITH ABT-333 OR ABT-267 ON miR-122 IN HCV-INFECTED SUBJECTS
    Waring, J. F.
    Dumas, E.
    Coakley, E.
    Cohen, D.
    Podsadecki, T.
    Dutta, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S331 - S331
1234